暂无分享,去创建一个
[1] L. Fraenkel,et al. Risk-attitude and patient treatment preferences , 2003, Lupus.
[2] Christel Baier,et al. Computing Quantiles in Markov Reward Models , 2013, FoSSaCS.
[3] Werner Vogels,et al. Dynamo: amazon's highly available key-value store , 2007, SOSP.
[4] Alexey Piunovskiy,et al. Dynamic programming in constrained Markov decision processes , 2006 .
[5] Georg Ch. Pflug,et al. Time-Consistent Decisions and Temporal Decomposition of Coherent Risk Functionals , 2016, Math. Oper. Res..
[6] P. Austin,et al. The use of quantile regression in health care research: a case study examining gender differences in the timeliness of thrombolytic therapy , 2005, Statistics in medicine.
[7] Shie Mannor,et al. Percentile Optimization for Markov Decision Processes with Parameter Uncertainty , 2010, Oper. Res..
[8] Huan Xu,et al. Dynamic programming for risk-aware sequential optimization , 2017, 2017 IEEE 56th Annual Conference on Decision and Control (CDC).
[9] Douglas K Owens,et al. Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Marek Petrik,et al. Tight Approximations of Dynamic Risk Measures , 2011, Math. Oper. Res..
[11] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[12] A. Vries. Value at Risk , 2019, Derivatives.
[13] Yan Xu,et al. Optimizing Quantiles in Preference-Based Markov Decision Processes , 2016, AAAI.
[14] Brian T. Denton,et al. Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patients , 2014, Eur. J. Oper. Res..
[15] Marco Pavone,et al. Risk aversion in finite Markov Decision Processes using total cost criteria and average value at risk , 2016, 2016 IEEE International Conference on Robotics and Automation (ICRA).
[16] Alexander Shapiro,et al. Convex Approximations of Chance Constrained Programs , 2006, SIAM J. Optim..
[17] Laurent El Ghaoui,et al. Robust Control of Markov Decision Processes with Uncertain Transition Matrices , 2005, Oper. Res..
[18] D. Krass,et al. Percentile performance criteria for limiting average Markov decision processes , 1995, IEEE Trans. Autom. Control..
[19] Daniel Kuhn,et al. Robust Markov Decision Processes , 2013, Math. Oper. Res..
[20] D. Duffie,et al. An Overview of Value at Risk , 1997 .
[21] Jeremy Berkowitz,et al. How Accurate are Value-at-Risk Models at Commercial Banks , 2001 .
[22] J. Michael Steele,et al. Markov Decision Problems Where Means Bound Variances , 2014, Oper. Res..
[23] Andrzej Ruszczynski,et al. Risk-averse dynamic programming for Markov decision processes , 2010, Math. Program..
[24] Jonathan AC Sterne,et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies , 2002, The Lancet.
[25] Shie Mannor,et al. Policy Gradients with Variance Related Risk Criteria , 2012, ICML.
[26] A. Beyerlein. Quantile regression-opportunities and challenges from a user's perspective. , 2014, American journal of epidemiology.
[27] Nicole Bäuerle,et al. Markov Decision Processes with Average-Value-at-Risk criteria , 2011, Math. Methods Oper. Res..
[28] Andrew J. Schaefer,et al. The Optimal Time to Initiate HIV Therapy Under Ordered Health States , 2008, Oper. Res..
[29] Marc G. Bellemare,et al. Distributional Reinforcement Learning with Quantile Regression , 2017, AAAI.
[30] John N. Tsitsiklis,et al. Optimal stopping of Markov processes: Hilbert space theory, approximation algorithms, and an application to pricing high-dimensional financial derivatives , 1999, IEEE Trans. Autom. Control..
[31] Marc G. Bellemare,et al. A Distributional Perspective on Reinforcement Learning , 2017, ICML.
[32] Mohammad Ghavamzadeh,et al. Algorithms for CVaR Optimization in MDPs , 2014, NIPS.
[33] Alexander Shapiro,et al. Risk neutral and risk averse Stochastic Dual Dynamic Programming method , 2013, Eur. J. Oper. Res..
[34] Shie Mannor,et al. Risk-Sensitive and Robust Decision-Making: a CVaR Optimization Approach , 2015, NIPS.
[35] John N. Tsitsiklis,et al. Mean-Variance Optimization in Markov Decision Processes , 2011, ICML.
[36] Jan M. Hoem,et al. Life Table , 2011, International Encyclopedia of Statistical Science.
[37] M. Freiberg,et al. HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan , 2016, Journal of the American Heart Association.
[38] Bart Selman,et al. Probabilistic planning with non-linear utility functions and worst-case guarantees , 2012, AAMAS.
[39] Warren B. Powell,et al. Risk-Averse Approximate Dynamic Programming with Quantile-Based Risk Measures , 2015, Math. Oper. Res..
[40] Stanislav Uryasev,et al. Conditional Value-at-Risk for General Loss Distributions , 2002 .
[41] E. Altman. Constrained Markov Decision Processes , 1999 .
[42] Linn I. Sennott,et al. Average Cost Semi-Markov Decision Processes and the Control of Queueing Systems , 1989, Probability in the Engineering and Informational Sciences.
[43] Dimitri P. Bertsekas,et al. Dynamic Programming and Optimal Control, Two Volume Set , 1995 .
[44] Patrick Cheridito,et al. Time-Inconsistency of VaR and Time-Consistent Alternatives , 2007 .
[45] T. Bärnighausen,et al. High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa , 2013, Science.
[46] R. Rockafellar,et al. Optimization of conditional value-at risk , 2000 .
[47] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[48] Daniel Hernández-Hernández,et al. Risk Sensitive Markov Decision Processes , 1997 .